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:  Postoperative analgesia following posterior spinal fusion 
surgery remains challenging; intrathecal morphine in conjunction with morphine PCA has been used to 
control pain in prior studies. 
:  Patients who receive intrathecal morphine for posterior spinal fusion surgery are 
able to directly transition to oral opioids, ambulate sooner, have their Foley catheters removed sooner, 
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  Posterior spinal fusion (PSF) to correct idiopathic scoliosis is associated with 
severe postoperative pain. Intrathecal morphine (ITM) is commonly used for analgesia after adolescent 
PSF; however, anticipating and managing the increase in pain scores after resolution of analgesic effect 
of intrathecal morphine analgesia is challenging. In 2014, we developed a clinical protocol detailing both 
the administration of intrathecal morphine intraoperatively and the transition to routine, scheduled oral 
analgesics at 18 hours postoperatively. The goal of our study was to examine the efficacy of our 
intrathecal morphine protocol versus epidural hydromorphone (EPI) for postoperative analgesia after 
PSF. 
Following IRB approval, we retrospectively identified developmentally intact children 
ages 10-20 years in our electronic database with a diagnosis of idiopathic scoliosis who had undergone 
elective PSF surgery from June 2014-April 2015.  For the ITM group, intrathecal morphine was 
administered in a dose of 12 mcg/kg (max 1000mcg) prior to incision. Postoperatively, all children in the 
ITM group had an order to receive oral oxycodone (0.1mg/kg, max 5mg) starting at 18 hours post-
intrathecal morphine injection.  For the EPI group, catheters were placed by the surgeon and bolused with 
5 mcg/kg hydromorphone (max 200 mcg) and 1 mcg/kg fentanyl (max 50 mcg), followed by a continuous 
infusion of 40-60 mcg/hr, and patient-controlled bolus doses of 5 mcg with a lockout interval of 30 
minutes.  All patients in both groups had postoperative orders for acetaminophen, diazepam, and 
ketorolac.   
During the study time period, 20 patients received intrathecal morphine and were 
successfully matched with 20 patients who received epidural hydromorphone. There were no differences 
in demographic or surgical characteristics between the two groups. All patients in the ITM group were 
transitioned to oral analgesics on the first postoperative day, without need for IV opioids after discharge 
from the PACU. Compared to the EPI group, the ITM group reported lower pain scores in the PACU 
- - -    -
-  and higher pain scores on the 2
nd
 The efficacy of intraoperative intrathecal morphine for postoperative analgesia in 
the PSF patient population has been shown previously; however, the pain and analgesic trajectory, 
including transition to other analgesics, has not previously been studied. Our findings suggest that for 
many patients, use of intrathecal morphine in addition to routine administration of non-opioid medications 
facilitates direct transition to oral analgesics in the early postoperative period and earlier routine 
ambulation and discharge of PSF patients. 
 postoperative day 
The documented time to ambulation and time of Foley catheter removal were statistically 
earlier in the ITM group, and the hospital length of stay was significantly shorter 
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Posterior spinal fusion (PSF) to correct idiopathic scoliosis is associated with severe 
postoperative pain.  Adequate and safe postoperative analgesia remains challenging and controversial, 
both among anesthesiologists and surgeons.
1-9
  Intrathecal opioids have been used to manage 
postoperative pain in pediatric patients for a wide variety of surgeries,
7
  including adolescent and adult 
PSF.
3-6, 9, 10
  Although these studies have shown reduction in pain on the first day following intrathecal 
injection, one of the biggest challenges associated with using intrathecal morphine for PSF is anticipating 
and managing the substantial increase in pain scores that occurs when the analgesic effect of intrathecal 
morphine wears off on the first postoperative day.
 3-6, 9, 10
 
At our institution, the standard of care for postoperative analgesia for adolescents undergoing 
PSF has been an epidural infusion containing hydromorphone as a sole agent.  While this method was 
shown to provide comparable pain relief as intravenous patient controlled analgesia (IV-PCA) for these 
patients,
8
 there are some disadvantages, including the concern for infection related to presence of a 
foreign body in the surgical site, the technical difficulties with the epidural pumps which remain a 
frustration for the bedside nurses, and the common occurrence of serous fluid leaking around the epidural 
site.  A single, intraoperative opioid dose administered via the intrathecal route obviates these problems 
and offers an alternative strategy for pain relief following spinal fusion.  
During the summer of 2014, we developed a clinical protocol for intraoperative administration of 
intrathecal morphine and postoperative transition to oral analgesics.  The impetus for this change in our 
institution’s postoperative pain control regimen for PSF surgery was initiated and supported by one of our 
pediatric orthopaedic surgeons who sought a simpler and efficacious approach to managing pain.  The 
purpose of this retrospective study was to 1) describe postoperative pain outcomes in children who 
received intrathecal morphine with this new clinical protocol, and 2) compare these outcomes to those in 
a group of children who received a previously established clinical protocol with epidural hydromorphone 
during the same period.  
 
Following approval from the Institutional Review Board at the University of Michigan and waiver of 
informed consent, we identified patients in our electronic surgical database with a diagnosis of idiopathic 
scoliosis who had undergone PSF and had received an intrathecal morphine injection between June 2014 
and April 2015 (ITM group). We matched these patients by age (± 2 years) and gender to adolescents 
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patients aged 10-20 years that were developmentally normal and had an American Society of 
Anesthesiologists (ASA) physical status I, II, or III. All others were excluded.  
For the ITM group, intrathecal morphine was administered in a dose of 12 mcg/kg (max 1000 
mcg) by or under the supervision of the anesthesiologist immediately after induction of anesthesia and 
prior to incision.  This dose was based on data from Tripi et al
5
, where their moderate dose group (mean 
14 mcg/kg, range 9-19 mcg/kg of intrathecal morphine) had significantly less respiratory complications 
and intensive care unit admissions compared to the high dose group (mean 24 mcg/kg, 20 mcg/kg 
minimum of intrathecal morphine).   Postoperatively, all children in the ITM group had an order to receive 
oral oxycodone (0.1mg/kg, max 5mg) starting at 18 hours post-intrathecal morphine injection. For children 
in the EPI group, catheters were placed by the surgeon at the end of the operation and bolused with 5 
mcg/kg hydromorphone (maximum dose 200 mcg) and 1 mcg/kg of fentanyl (max 50 mcg), followed by a 
continuous infusion of 40-60 mcg/hr, and patient-controlled bolus doses of 5mcg with a lockout interval of 
30 minutes.   
8
  General anesthetic technique and administration of IV opioids and benzodiazepines during the 
perioperative period were at the discretion of the anesthesiologist.   After recovery in the post-anesthesia 
care unit, these patients were admitted directly to a general pediatric floor. 
Post-operatively, all patients in both groups had orders for IV or oral diazepam as needed (dose 
of 0.05mg/kg for the first 24 hours in the ITM group, then increasing to 0.1mg/kg; dose of 0.1mg/kg in the 
EPI group for all time periods), ketorolac (0.5mg IV/max 15mg), and acetaminophen (15mg/kg po) were 
ordered to be given around the clock throughout the postoperative period.  For the EPI group, transition to 
oral oxycodone occurred upon removal of the epidural, either on postoperative day #2 or #3, at the 
discretion of the surgeon and the anesthesiologist rounding on the acute pain service.          
Trained research assistants reviewed the electronic medical records to record all pain scores (0-
10 self-reported numeric rating scale), administration of all opioid and non-opioid analgesics, and opioid 
antagonists.  Additionally, they recorded sedation scores (University of Michigan Sedation Scale, range 0-
4 where 4=unarousable); episodes of nausea, vomiting, and pruritus; administration of antiemetics and 
antipruritics; use of supplemental oxygen; time of first oral intake; time of hospital discharge; and 
evidence of any other adverse events, including admission to the intensive care unit.   
 Our primary outcomes were pain scores, opioid use after postoperative day 1, and adverse 
events. Our secondary outcome was length of stay (LOS).  Data were analyzed using Statistical Package 
for the Social Sciences (SPSS) software (v. 21, IBM, New York).  Data are presented as n (%) or mean ± 
standard deviation (SD) as appropriate.  Nominal data were compared between ITM and EPI groups 
using chi square analyses and parametric data, with unpaired t tests.  Pain intensity scores were treated 
as interval data and compared between groups at specific time intervals using unpaired t tests.  
Additionally, these data were restructured and a linear mixed model analysis using the maximum 
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values less than 0.05 were considered significant and Bonferroni corrections applied where applicable 
(example, repeated measures). 
 
Twenty patients received intrathecal morphine during the study period.  Twenty out of 38 patients 
who received epidural hydromorphone from the same time period were matched to the patients in the ITM 
group, giving a total sample size of 40 patients.  There were no differences in demographic and surgical 
characteristics between the groups (Table 1). The perioperative analgesics administered are depicted in 
Table 2. The mean dose of morphine used in the ITM group was 11.3 mcg/kg ± 1.2.  The concentration of 
the hydromorphone infusion in the EPI group was 5 mcg/ml for 19 of the patients and 10 mcg/ml for 1 
patient, and the mean rate was 5.1 ± 5.3 mL/hr with patient-controlled bolus doses of 0.88 ± 0.94 mL.  
Epidural infusions ran for 30.5 to 45.57 hours (mean 42.08 ± 3.64), after which time oral oxycodone was 
initiated. All patients who received intrathecal morphine were successfully and directly transitioned to oral 
oxycodone on the first postoperative day without the need for IV opioid rescue.   
Pain and Analgesic Outcomes 
Table 3 presents the postoperative analgesics received by children in the ITM and EPI groups. 
Oral morphine equivalents were significantly lower for children in the ITM group on day 2, but were similar 
thereafter.  s the means of the highest and lowest recorded pain scores of the two groups 
over the first 3 postoperative days, and 
.  
    )  -
 Overall, the linear mixed model demonstrated a significant effect of 
time on pain scores (F=4.28 (df 1); estimate 0.269 [95% confidence interval 0.010, 0.529], p=0.042), but 
no effect of Group (F=2.35 (df1); estimate -0.83 [95% CI -1.93, 0.26], p=0.132).  The overall estimated 
marginal mean high pain score for the ITM group was 4.38 [95% CI 3.59, 5.17] compared to 5.22 [95% CI 
4.43, 6.00]; p=0.132. The documented time to ambulation was statistically earlier in the ITM group (21.8 
± 5.5 vs 28.8 ±12.2 hours; p= 0.028), as was the documented time of Foley catheter removal (21.5 ± 8.1 
hours vs 40.5 ± 13.1 hours; p< 0.001).  Also, the hospital length of stay was significantly shorter in the 
ITM group (3.0 ±0.5 days vs. 3.5 ± 0.7 days; p= 0.03).     
Opioid-related Adverse Events 
5. Both groups 
experienced similarly high rates of nausea/vomiting and pruritus.  Two patients in the ITM group were 
admitted to the pediatric intensive care unit for closer neurological and blood pressure monitoring 
following transient loss of transcranial electric motor-evoked potentials (MEPs) intraoperatively.  Both of 
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above 70 mmHg, per surgical request following loss of MEPs intra-operatively.  The first patient received 
740 mcg intrathecal morphine (11.8mcg/kg) and a length of surgery 422 minutes.  While in the PICU, this 
patient received 2L of normal saline bolus and had a norepinephrine infusion (0.01mg/kg/min) for a total 
of 2.5 hours.  The second patient had received 600 mcg intrathecal morphine (11.5 mcg/kg), and a length 
of surgery of 341 minutes.  This patient was also started on a norepinephrine infusion (titrated to a max of 
0.05mg/kg/min) for about 9 hours, in addition to receiving a total of 3L crystalloid bolus while in the PICU.  
Both of these children were discharged home without any neurologic deficits. 
One third of children in both groups required nasal cannula oxygen to maintain SpO2
 
 >92% at 
some point after PACU discharge, however none required naloxone or additional treatment for 
hypoxemia.  All patients in both the ITM and EPI groups received at least 2 antiemetic drugs 
intraoperatively, usually ondansetron and dexamethasone, and many received diphenhydramine as a 
third agent.  Despite this, based on rates of administration of anti-emetics, the incidence of postoperative 
nausea and vomiting was 90% in the ITM group and 80% in the EPI group ( ).  One patient from 
the EPI group required straight catheterization for urinary retention after the epidural was removed.  No 
incidence of postdural puncture headache was noted for either group.   
The efficacy of intraoperative administration of intrathecal morphine for postoperative analgesia in 
the PSF patient population has been shown previously.
3-6, 9, 10
  However, the pain and analgesic 
trajectory, including transition to oral analgesics, has not been previously studied and has remained a 
challenge. Our findings suggest that in our setting, use of intrathecal morphine in addition to routine 
administration of non-opioids facilitated direct transition to oral analgesics in the early postoperative 
period with effective analgesia that facilitated early ambulation and discharge.   
Not surprisingly, intrathecal morphine appeared to be most effective in controlling pain during the 
first 16 hours postoperatively. After this point, pain scores significantly increased for the ITM group 
compared to the EPI group, which had relatively stable pain scores over time.  Importantly, our routine 
practice is to administer the first rescue opioid at 18 hours from the time of the intrathecal morphine 
injection.    
   
-
 .  Our protocol does emphasize postoperative use of non-opioids 
(acetaminophen and ketorolac) around the clock to help facilitate analgesia during and after this 
transition.  
While our rates of nausea and vomiting were high in the ITM group, they were nearly as high in 
our EPI group, suggesting that both routes of opioid administration are similarly associated with this 
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but similar to prospective studies where children are asked directly about nausea.
9
  It may be that our 
clinicians assess and treat this effect more readily than in other settings.  Our reported rates of nausea 
were inferred from the administration of antiemetic drugs by nursing staff, and it is possible that in some 
cases, antiemetics were given in a prophylactic fashion, thus artificially increasing our reported rates of 
nausea.  Nonetheless, it is clear that management of this very troublesome side effect in this high risk 
patient population could be improved.   
No serious adverse outcomes were noted in terms of persistent neurologic deficits or respiratory 
depression requiring intervention beyond nasal cannula oxygen.  Thirty-eight patients were managed in 
general pediatric care units postoperatively; two patients were admitted to the PICU for close 
neurovascular monitoring due to transient loss of transcranial electric motor-evoked potentials 
intraoperatively.  Both of these patients required vasopressors for blood pressure augmentation.  It is 
possible that the use of intrathecal morphine at the doses we used increased the risk for hypotension 
compared to with other methods of analgesia.  Adequate fluid resuscitation for these patients is difficult, 
given the relatively high blood loss associated with PSF concurrent with the desire to avoid high volume 
crystalloid resuscitation as it is associated with increased risk for postoperative visual loss in these 
surgeries.
11-13
  Nonetheless, it remains important to recognize, monitor for, and intervene to prevent or 
treat hypotension when intrathecal morphine is used during PSF.   
Notably, intrathecal morphine was associated with a decreased length of stay in this small sample 
of children.   in the early 
postoperative period, which better facilitated physical therapy and mobility.  Earlier Foley catheter 
removal and ambulation in the ITM group may have been related, in part,  
 may also have contributed to a shorter hospital stay.  The multidisciplinary 
care plan for PSF patients in our setting has now incorporated earlier mobility goals and expectations 
given the ITM protocol, and planned discharge on postoperative day 2 is now thought to be achievable for 
many patients . 
The ability to generalize our data is limited by the retrospective nature of this study and the 
possibility of confounding, undocumented factors. We cannot overlook the possibility of reporting bias 
since our data were extracted from nursing and medical records where underreporting of adverse events 
is likely. Additionally, our use of medication administration as a proxy for adverse events may have 
resulted in an over-estimation of events since nurses often administer these agents prophylactically.  
Lastly, given our small sample size, it is quite likely that this study was underpowered to detect 
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In summary, intrathecal morphine, in conjunction with adequate non-opioid adjuvants, was well 
tolerated and facilitated direct transition to oral analgesics in the early postoperative period in our small 
sample size of adolescents who underwent PSF for idiopathic scoliosis.  
approved by University of Michigan IRB, ID:  HUM00094624, February 16, 2015 
The study was funded by departmental resources. 
No conflicts of interest declared. 
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Table 1.  Demographics and Surgical Characteristics of the Groups 
 Intrathecal Morphine  
(n = 20) 
Epidural 
Hydromorphone (n = 
20) 
Mean difference [95% 
confidence interval], p 
value 
Age (years) 13.3 ± 2.3  
(range 10-20y) 
13.5 ± 1.7  
(range 10-17y) 
 
Male 2 (10%) 2 (10%) A 
Weight (kg) 55.6 ± 15.1 58.0 ±15.3   
ASA 1/2/3 7 (35%) /13 (65%) /0 8 (40%) /10 (50%) /2 
(10%) 
N/A 
Number of Spinal levels 
fused (median) 
9.5 (range 6-12) 10 (range 7-12) 0.281 [-0.730, 0.448],  
0.621 
Major preoperative curve 
magnitude (degrees) 
55.7 ± 9.3 55.2 ± 11.0 0.193 [-0.583, 0.229],  
0.372 
Length of surgery (minutes) 264.65 ± 57.61 252.80 ± 46.53 11.85 [-21.72, 45.42],  
0.479 
Data presented as mean ± SD and n (%). 
 
 
Table 2. Intravenous Analgesics administered during and immediately after surgery in the Intrathecal 
Morphine (ITM) and Epidural (EPI) Groups  
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Drug ITM EPI ITM EPI 
Sufentanil (n [%]) 0 15 (75%) N/A N/A 
 P<0.001; 4 [1.872, 8.545]   
Remifentanil 12 (60%) 4 (20%) N/A N/A 
 P=0.022; 0.167 [0.041, 0.686]   
Dexmedetomidine 13 (65%) 14 (70%) N/A N/A 
 P=1.000; 1.256 [0.334, 4.733]   
Fentanyl 20 (100%) 17 (85%) 1 (5%) 5 (25%) 
 P=0.231; 1.176 [0.979, 1.414] P=0.182; 6.333 [0.667, 60.163] 
Morphine (IV) 0 0 1 (5%) 0 
   P=1.000; 0.950 [0.859, 1.050] 
Hydromorphone (IV) 0 2 (10%) 0 1 (5%) 
 P=0.487; 1.111 [0.960, 1.286] P=1.000; 1.053 [0.952, 1.164] 
Acetaminophen (IV) 
(mg/kg ± SD) 
16 (80%) 
11.0 ± 6.0 
16 (80%) 
11.0 ± 9.0 
1 (5%) 
0.60 ± 2.67 
5 (25%) 
3.32 ± 6.09 
 P=1.000; 0.818 [0.236, 2.835] P=0.182; 6.333 [0.667, 60.163] 
Ketorolac 17 (85%) 13 (65%) 4 (20%) 3 (15%) 
 P=0.273; 0.328 [0.071, 1.518] P=1.000; 0.706 [0.136, 3.658] 
Diazepam 3 (15%) 12 (60%) 6 (30%)* 12 (60%)* 
 P=0.008; 8.500 [1.861, 38.817] P=0.111; 3.500 [0.945, 12.966] 
Ketamine 2 (10%) 2 (10%) 0 0 
 P=1.000; 1.000 [0.127, 7.893]   
Midazolam (IV) 16 (80%) 18 (90%) 0 0 
 P=0.661; 2.250 [0.362, 13.971]   
Nalbuphine 0 0 1 (5%) 1 (5%) 
   P=1.000; 1.000 [0.058, 17.181] 
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Table 3.  Total Postoperative Intravenous and Oral Analgesic Doses (mg/kg/day) in the Intrathecal Morphine (ITM) and Epidural (EPI) Groups 













Oral Morphine equivalents N/A N/A 0.19 ± 0.07 0.06 ± 0.06 0.16 ± 0.08 0.19 ± 0.07 
  <0.001; 0.128 [0.088, 0.167] 0.301; -0.024 [-0.071, 0.023] 
Intravenous Diazepam 0.12 ± 0.07 0.14 ± 0.08 0.18 ± 0.09 0.23 ± 0.10 0.18 ± 0.12 0.18 ± 0.11 
 0.443; -0.019 [-0.070, 0.031] 0.105; -0.051 [-0.112, 0.011] 0.987; -0.001 [-0.077, 0.076] 
Oral Acetaminophen 33.62 ± 12.77 19.67 ± 13.88  42.05 ± 18.05 32.74 ± 13.82 36.21 ± 18.35 34.44 ± 13.70 
 0.002; 13.945 [5.298, 22.593] 0.075; 9.306 [-1.009, 19.620] 0.736; 1.771 [-8.721, 12.263] 
Intravenous Ketorolac 0.93± .29 0.94 ± 0.38 0.77 ± 0.50 1.01 ± 0.38 0.08 ± 0.27 0.10 ± 0.18 
 0.952; -0.006 [-0.221, 0.208] 0.094; -0.239 [-0.521, 0.043] 0.853; -0.014 [-0.163, 0.136] 























 -4.26 (-6.56, -1.96), 0.001 -3.12 (-4.66, -1.57), <0.001 
0-  -1.88 (-3.84, 0.82), 0.060 --1.95 (-3.25, -0.66), 0.006 
8-  -0.96 (-2.65, 0.73), 0.251 -2.04 (-3.50, -0.59), 0.008 
-  0.018 (-1.55, 1.59), 0.981 -0.85 (-2.16, 0.45), 0.193 
-  1.60 (0.10, 3.10), 0.037 -0.11 (-1.33, 1.10), 0.851 






.  Adverse Events Throughout Hospital Stay in the Intrathecal Morphine (ITM) and Epidural (EPI) 
groups 
Adverse event ITM EPI 
Postoperative nausea or 
vomiting 
18 (90%) 16 (80%) 
Pruritus 8 (40%) 13 (65%) 
Use of Nasal Cannula Oxygen 7 (35%) 7 (35%) 
Over sedation (per chart notes) 0 3 (15%) 
Unplanned admission to 
intensive care unit  
2 (10%) 0 
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Legend for Figure 1:  Highest and lowest reported mean pain scores for each time period from the 
intrathecal morphine (ITM) and epidural (EPI) groups.   
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